NEVVI Medicare utilization intelligence

← back

DY, PHILIPM.D. NPI 1710076567 Clinician

Medical Oncology · EFFINGHAM, IL

Specialty Medical Oncology — from billed Medicare claims
In practice about 37 years since medical school (class of 1989, self-reported to CMS)
Location EFFINGHAM, IL · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 103 codes billed · 540,971 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS SC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-07

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0185 Injection, aprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J0897 Injection, denosumab, 1 mg
J1930 Injection, lanreotide, 1 mg
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1449 Injection, eflapegrastim-xnst, 0.1 mg
J2469 Injection, palonosetron hcl, 25 mcg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
80053 Blood test, comprehensive group of blood chemicals
83735 Magnesium level
36415 Insertion of needle into vein for collection of blood sample
83615 Lactate dehydrogenase (enzyme) level
J0640 Injection, leucovorin calcium, per 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J9190 Injection, fluorouracil, 500 mg
96372 Injection of drug or substance under skin or into muscle
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
96413 Administration of chemotherapy into vein, 1 hour or less
J1200 Injection, diphenhydramine hcl, up to 50 mg
96375 Injection of additional new drug or substance into vein
J3475 Injection, magnesium sulfate, per 500 mg
82784 Gammaglobulin (immune system protein) measurement
88185 Flow cytometry technique for dna or cell analysis, each additional marker
J3480 Injection, potassium chloride, per 2 meq
82378 Carcinoembryonic antigen (cea) protein level
J9045 Injection, carboplatin, 50 mg
83540 Iron level
83550 Iron binding capacity
82728 Ferritin (blood protein) level
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
85045 Red blood count, automated test
82607 Cyanocobalamin (vitamin b-12) level
96361 Infusion into a vein for hydration, each additional hour
83521 Measurement of immunoglobulin light chains
82746 Folic acid level, serum
96417 Administration of additional new drug or substance into vein, 1 hour or less
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
84443 Blood test, thyroid stimulating hormone (tsh)
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
84439 Thyroxine (thyroid chemical), free
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J1750 Injection, iron dextran, 50 mg
96374 Injection of drug or substance into vein
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
84153 Psa (prostate specific antigen) measurement, total
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
82232 Beta-2 microglobulin (protein) level
J7030 Infusion, normal saline solution , 1000 cc
J3489 Injection, zoledronic acid, 1 mg
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
82306 Vitamin d-3 level
96360 Infusion into a vein for hydration, 31-60 minutes
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
71260 Ct scan of chest with contrast
84550 Uric acid level, blood
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
84100 Phosphate level
83010 Haptoglobin (serum protein) level
74177 Ct scan of abdomen and pelvis with contrast
96411 Administration of additional new drug or substance into vein using push technique
99427 Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month
99195 Drawing of blood for a medical problem
96523 Irrigation of implanted venous access drug delivery device
36591 Collection of blood sample from implanted device
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
80061 Blood test, lipids (cholesterol and triglycerides)
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
J2060 Injection, lorazepam, 2 mg
99443 Telephone medical discussion with physician, 21-30 minutes
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme
94640 Inhalation treatment for airway obstruction or sputum production
71250 Ct scan of chest without contrast
82668 Erythropoietin (protein) level
78816 Nuclear medicine study whole body with ct scan
88184 Flow cytometry technique for dna or cell analysis, first marker
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
99442 Telephone medical discussion with physician, 11-20 minutes
38222 Biopsy and aspiration of bone marrow sample for diagnosis
81001 Manual urinalysis test with examination using microscope, automated
82565 Blood creatinine level
84520 Urea nitrogen level to assess kidney function, quantitative

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.